Evidence map›Paper›PMID 41268541›Full record

ArticleFrontiers in immunology2025

Identification of glycolysis-related clusters and immune cell infiltration in hepatic fibrosis progression using machine learning models and experimental validation.

Guanglin Xiao, Zhiling Deng, Ke Qiu, Aoyi Li, Xingyue Yi, Hong Ren

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Guanglin XiaoDepartment of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases, Ministry of Education, Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Zhiling DengDepartment of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases, Ministry of Education, Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Ke QiuDepartment of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases, Ministry of Education, Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Aoyi LiDepartment of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases, Ministry of Education, Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Xingyue YiDepartment of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases, Ministry of Education, Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Hong RenDepartment of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases, Ministry of Education, Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Although glycolytic reprogramming constitutes a fundamental driver of hepatic fibrosis (HF), its precise mechanistic contributions remain incompletely characterized. This investigation systematically identified molecular signatures of glycolysis-related genes (GRGs) in HF. We further developed a glycolytic activity-based model for HF risk stratification. Methods: Integrated analysis of GEO datasets (GSE276114, GSE84044, GSE49541) identified differentially expressed genes (DEGs) associated with HF progression. Integrated weighted gene co-expression network analysis (WGCNA) with six machine learning algorithms to identify core GRGs genes associated with HF progression, and systematically characterized their biological functions and immunoregulatory roles through immune infiltration assessment, functional enrichment, consensus clustering, and single-cell differential state analysis. Glycolytic activity was evaluated in CCl Results: Through the intersection of WGCNA, DEGs, and GRGs, machine learning identified six core GRGs: B3GNT3, CHST4, DCN, GPC3, SOX9, and VCAN. Based on the core GRGs, three GRG-based molecular subtypes were defined. Cluster C, with higher expression of the core GRGs, exhibited significantly enhanced immune infiltration, particularly of adaptive immune cells compared to Cluster A and B. Cluster C comprised a mixed landscape of T cells, mast cells, and pro-fibrogenic cells, distinct from the innate immune-dominant profiles of Clusters A and B. Both Conclusions: Glycolytic reprogramming is a key pathogenic driver in HF progression and associated immune infiltration. Investigating this metabolic-immune dysregulation represents a promising therapeutic focus for progression of HF.

Indexed as

GlycolysisLiver CirrhosisMachine LearningAnimalsCell LineDisease Models, AnimalDisease ProgressionGene Expression ProfilingGene Regulatory NetworksHumansMaleMiceTranscriptomeglycolytic reprogramminghepatic fibrosisimmune cell infiltrationmachine learningWGCNA

Identifiers

PMID41268541
PMCPMC12626809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.